BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Woude CJ, Kleibeuker JH, Tiebosch AT, Homan M, Beuving A, Jansen PL, Moshage H. Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins. J Clin Pathol. 2003;56:699-702. [PMID: 12944556 DOI: 10.1136/jcp.56.9.699] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Takao Real Karia B, Albuquerque Pinto C, Gigek CO, Wisnieski F, Arruda Cardoso Smith M. Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastric Cancer: From EMT to Drug Resistance. Onco 2021;1:140-157. [DOI: 10.3390/onco1020012] [Reference Citation Analysis]
2 Portillo Miño JD, Araujo Prado LM, Melo Yepes JM, Carlosama Rosero YH. Características sociodemográficas e histopatológicas en pacientes con cáncer gástrico en una población con alto riesgo en Colombia. Rev colomb Gastroenterol 2021;36:18-23. [DOI: 10.22516/25007440.544] [Reference Citation Analysis]
3 Scarpa ES, Tasini F, Crinelli R, Ceccarini C, Magnani M, Bianchi M. The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells. Int J Mol Sci 2020;21:E5435. [PMID: 32751694 DOI: 10.3390/ijms21155435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
4 Chen J, Xia D, Xu M, Su R, Lin W, Guo D, Chen G, Liu S. Expression and Significance of MyD88 in Patients With Gastric Cardia Cancer in a High-Incidence Area of China. Front Oncol 2020;10:559. [PMID: 32477927 DOI: 10.3389/fonc.2020.00559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Gupta MK, Rajeswari J, Reddy PR, Kumar KS, Chamundeswaramma KV, Vadde R. Genetic Marker Identification for the Detection of Early-Onset Gastric Cancer Through Genome-Wide Association Studies. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers 2020. [DOI: 10.1007/978-981-15-4431-6_11] [Reference Citation Analysis]
6 Tiwari SK, Shaik AS, Shaik AP, Alyousef AA, Bardia A, Habeeb MA, Khan AA. Gene expression patterns of COX-1, COX-2 and iNOS in H. Pylori infected histopathological conditions. Microb Pathog 2019;135:103634. [PMID: 31325568 DOI: 10.1016/j.micpath.2019.103634] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
7 Wang CJ, Zhu CC, Xu J, Wang M, Zhao WY, Liu Q, Zhao G, Zhang ZZ. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18:115. [PMID: 31272462 DOI: 10.1186/s12943-019-1032-0] [Cited by in Crossref: 127] [Cited by in F6Publishing: 147] [Article Influence: 31.8] [Reference Citation Analysis]
8 Dong P, Ji X, Han W, Han H. Oxymatrine attenuates amyloid beta 42 (Aβ 1–42 )-induced neurotoxicity in primary neuronal cells and memory impairment in rats. Can J Physiol Pharmacol 2019;97:99-106. [DOI: 10.1139/cjpp-2018-0299] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Oliveira LA, Oshima CTF, Soffner PA, Silva MS, Lins RR, Malinverni ACM, Waisberg J. THE CANONICAL WNT PATHWAY IN GASTRIC CARCINOMA. Arq Bras Cir Dig 2019;32:e1414. [PMID: 30624523 DOI: 10.1590/0102-672020180001e1414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Mohsenzadeh M, Sadeghi RN, Vahedi M, Kamani F, Hashemi M, Asadzadeh H, Zali MR. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes. Cancer Biomark 2017;20:7-15. [PMID: 28759951 DOI: 10.3233/CBM-160331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
12 Lee S, Lee J, Choi IJ, Kim YW, Ryu KW, Kim YI, Oh JK, Tran BT, Kim J. Dietary inflammatory index and the risk of gastric cancer in a Korean population. Oncotarget 2017;8:85452-62. [PMID: 29156732 DOI: 10.18632/oncotarget.20008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
13 Abdel-Aziz A, Ahmed RA, Ibrahiem AT. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages. Ann Diagn Pathol 2017;30:1-7. [PMID: 28965621 DOI: 10.1016/j.anndiagpath.2017.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
14 Wang B, Sun K, Zou Y. Comparison of a Panel of Biomarkers Between Gastric Primary Cancer and the Paired Krukenberg Tumor. Appl Immunohistochem Mol Morphol 2017;25:639-44. [PMID: 26945444 DOI: 10.1097/PAI.0000000000000347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Sampaio AM, Balseiro SC, Silva MR, Alarcão A, d'Aguiar MJ, Ferreira T, Carvalho L. Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population. GE Port J Gastroenterol 2015;22:143-52. [PMID: 28868397 DOI: 10.1016/j.jpge.2015.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
16 Ponce CC, de Lourdes Lopes Ferrari Chauffaille M, Ihara SS, Silva MR. Increased angiogenesis in primary myelofibrosis: latent transforming growth factor-β as a possible angiogenic factor. Rev Bras Hematol Hemoter 2014;36:322-8. [PMID: 25305163 DOI: 10.1016/j.bjhh.2014.07.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Ashour DS, Othman AA, Radi DA. Insights into regulatory molecules of intestinal epithelial cell turnover during experimental infection by Heterophyes heterophyes. Exp Parasitol 2014;143:48-54. [PMID: 24852217 DOI: 10.1016/j.exppara.2014.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gryko M, Pryczynicz A, Zareba K, Kędra B, Kemona A, Guzińska-Ustymowicz K. The expression of Bcl-2 and BID in gastric cancer cells. J Immunol Res 2014;2014:953203. [PMID: 24741635 DOI: 10.1155/2014/953203] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
19 Chang EY, Tsai SH, Shun CT, Hee SW, Chang YC, Tsai YC, Tsai JS, Chen HJ, Chou JW, Lin SY, Chuang LM. Prostaglandin reductase 2 modulates ROS-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients. Am J Pathol 2012;181:1316-26. [PMID: 22998775 DOI: 10.1016/j.ajpath.2012.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
20 Onitilo AA, Aryal G, Engel JM. Hereditary diffuse gastric cancer: a family diagnosis and treatment. Clin Med Res. 2013;11:36-41. [PMID: 22723466 DOI: 10.3121/cmr.2012.1071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gryko M, Pryczynicz A, Guzińska-Ustymowicz K, Kamocki Z, Zaręba K, Kemona A, Kędra B. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors. Adv Med Sci 2012;57:77-83. [PMID: 22440942 DOI: 10.2478/v10039-012-0012-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ponce CC, de Lourdes F Chauffaille M, Ihara SS, Silva MR. The relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis. Med Oncol 2012;29:2337-44. [PMID: 22200991 DOI: 10.1007/s12032-011-0144-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
23 Ponce CC, Chauffaille Mde L, Ihara SS, Silva MR. MPL immunohistochemical expression as a novel marker for essential thrombocythemia and primary myelofibrosis differential diagnosis. Leuk Res 2012;36:93-7. [PMID: 21752469 DOI: 10.1016/j.leukres.2011.06.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Silva-Fernandes IJ, Alves MK, Lima VP, de Lima MA, Barros MA, Ferreira MV, Rabenhorst SH. Differential expression of MYC in H. pylori-related intestinal and diffuse gastric tumors. Virchows Arch 2011;458:725-31. [PMID: 21538123 DOI: 10.1007/s00428-011-1085-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Lima VP, Silva-Fernandes IJ, Alves MK, Rabenhorst SH. Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian’s patients: an association with histopathological parameters. Cancer Epidemiol. 2011;35:e32-e37. [PMID: 21470935 DOI: 10.1016/j.canep.2011.02.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
26 Sonoda R, Naomoto Y, Shirakawa Y, Fujiwara Y, Yamatsuji T, Noma K, Tanabe S, Takaoka M, Gunduz M, Tsujigiwa H. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett’s oesophagus and intestinal-type gastric carcinoma. Histopathology. 2010;57:90-100. [PMID: 20653782 DOI: 10.1111/j.1365-2559.2010.03594.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
27 Begnami MD, Montagnini AL, Vettore AL, Nonogaki S, Brait M, Simoes-Sato AY, Seixas AQA, Soares FA. Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas. World J Gastroenterol 2006; 12(31): 4959-4965 [PMID: 16937490 DOI: 10.3748/wjg.v12.i31.4959] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
28 Liu FY, Qi JP, Xu FL, Wu AP. Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor. World J Gastroenterol 2006; 12(26): 4161-4165 [PMID: 16830365 DOI: 10.3748/wjg.v12.i26.4161] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
29 Sun Y, Chen XY, Liu J, Cheng XX, Wang XW, Kong QY, Li H. Differential caspase-3 expression in noncancerous, premalignant and cancer tissues of stomach and its clinical implication. Cancer Detect Prev. 2006;30:168-173. [PMID: 16697119 DOI: 10.1016/j.cdp.2006.02.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
30 Bancel B, Estève J, Souquet JC, Toyokuni S, Ohshima H, Pignatelli B. Differences in oxidative stress dependence between gastric adenocarcinoma subtypes. World J Gastroenterol 2006; 12(7): 1005-1012 [PMID: 16534838 DOI: 10.3748/wjg.v12.i7.1005] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
31 Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer. 2005;41:2792-2805. [PMID: 16290133 DOI: 10.1016/j.ejca.2005.09.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 3.2] [Reference Citation Analysis]
32 Malta-Vacas J, Aires C, Costa P, Conde AR, Ramos S, Martins AP, Monteiro C, Brito M. Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J Clin Pathol 2005;58:621-5. [PMID: 15917414 DOI: 10.1136/jcp.2004.021774] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
33 Liu P, You SH, Zhang XY, Zhang DF, Ding XJ. Heterozygosity loss of fragile histidine triad gene in gastric cancer and precancerous lesions. Shijie Huaren Xiaohua Zazhi 2005; 13(10): 1190-1193 [DOI: 10.11569/wcjd.v13.i10.1190] [Reference Citation Analysis]
34 Qi JP, Xu FL, Wu AP. Expression of p21WAF1 and Bax in gastrointestinal stromal tumors and its clinical significance. Shijie Huaren Xiaohua Zazhi 2004; 12(11): 2642-2645 [DOI: 10.11569/wcjd.v12.i11.2642] [Reference Citation Analysis]